Information Journal Paper
APA:
Copy. (2017). Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial-mesenchymal transition. CANCER BIOLOGY AND THERAPY, 18(-), 965-973. SID. https://sid.ir/paper/736514/en
Vancouver:
Copy. Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial-mesenchymal transition. CANCER BIOLOGY AND THERAPY[Internet]. 2017;18(-):965-973. Available from: https://sid.ir/paper/736514/en
IEEE:
Copy, “Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial-mesenchymal transition,” CANCER BIOLOGY AND THERAPY, vol. 18, no. -, pp. 965–973, 2017, [Online]. Available: https://sid.ir/paper/736514/en